Enzo Other Liab from 2010 to 2024

ENZ Stock  USD 1.08  0.05  4.85%   
Enzo Biochem Other Liabilities yearly trend continues to be fairly stable with very little volatility. Other Liabilities will likely drop to 4,275 in 2024. During the period from 2010 to 2024, Enzo Biochem Other Liabilities regression line of annual values had r-squared of  0.76 and arithmetic mean of  597,718. View All Fundamentals
 
Other Liabilities  
First Reported
2000-01-31
Previous Quarter
K
Current Value
18 K
Quarterly Volatility
385 K
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Enzo Biochem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Enzo Biochem's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.5 M, Interest Expense of 187.2 K or Total Revenue of 63.1 M, as well as many indicators such as Price To Sales Ratio of 1.73, Dividend Yield of 2.0E-4 or PTB Ratio of 0.98. Enzo financial statements analysis is a perfect complement when working with Enzo Biochem Valuation or Volatility modules.
  
Check out the analysis of Enzo Biochem Correlation against competitors.
For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.

Latest Enzo Biochem's Other Liab Growth Pattern

Below is the plot of the Other Liab of Enzo Biochem over the last few years. It is Enzo Biochem's Other Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Enzo Biochem's overall financial position and show how it may be relating to other accounts over time.
Other Liab10 Years Trend
Slightly volatile
   Other Liab   
       Timeline  

Enzo Other Liab Regression Statistics

Arithmetic Mean597,718
Geometric Mean121,258
Coefficient Of Variation106.78
Mean Deviation542,225
Median424,000
Standard Deviation638,267
Sample Variance407.4B
Range1.6M
R-Value(0.87)
Mean Square Error107B
R-Squared0.76
Significance0.000025
Slope(124,107)
Total Sum of Squares5.7T

Enzo Other Liab History

2024 4275.0
2023 4500.0
2020 5000.0
201931 K
2017424 K
2016410 K
2015800 K

About Enzo Biochem Financial Statements

Enzo Biochem investors use historical fundamental indicators, such as Enzo Biochem's Other Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Enzo Biochem. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Liabilities4.5 K4.3 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Enzo Stock Analysis

When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.